Metastatic Breast Cancer: Biomolecular Characterization and Targeted Therapy
Author
Summary, in English
The aim of the research presented in this thesis was to characterize the biomolecular heterogeneity of breast cancer across tumor progression stages and to identify novel biomarkers and therapeutic strategies which may improve prognostication and personalization of therapy for women diagnosed with metastatic breast cancer.
By analysis of tumor biopsies collected at different stages of disease progression, we showed that, in general, the phenotype of the primary tumor is typically conserved during tumor progression. However, in a clinically relevant number of cases, a phenotypic drift in biomarkers and tumor molecular subtypes occurs longitudinally with disease progression, with a change to a more aggressive phenotype being associated with an inferior clinical outcome. We also uncovered that breast cancer liver metastases are transcriptionally different from metastases in other anatomical sites and identified candidate liver metastasis-selective genes with the potential to specifically predict liver metastatic relapse and more generally, the time to any recurrence in early stage breast cancer. Furthermore, we demonstrated that co-targeting of PARP1 and PI3K may represent an improved and specific treatment strategy for BRCA1 deficient breast cancers.
The results we present continue to emphasize the clinical significance of breast cancer heterogeneity and highlight possible ways to improve the accuracy of predicting prognosis and effectively treating patients with metastatic disease, a step towards achieving the promise of personalized cancer management and overcoming the clinical burden of metastatic breast cancer.
Department/s
- Breastcancer-genetics
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publishing year
2014
Language
English
Publication/Series
Lund University Faculty of Medicine Doctoral Dissertation Series
Volume
2014:70
Full text
Document type
Dissertation
Publisher
Oncology, MV
Topic
- Cancer and Oncology
Keywords
- Metastatic breast cancer
- biomarker conversion
- liver metastasis-selective genes
- prognosis
- BRCA1
- PARP1
Status
Published
Supervisor
- Ingrid Hedenfalk
- Pontus Berglund
- Sofia Gruvberger
- Niklas Loman
ISBN/ISSN/Other
- ISSN: 1652-8220
- ISBN: 978-91-87651-97-7
Defence date
12 June 2014
Defence time
09:00
Defence place
Föreläsningssalen, plan 3, Klinikgatan 5, Lund
Opponent
- Therese Sørlie (Associate Professor)